Atıf İçin Kopyala
Kroger N., Zander A., Martinelli G., Ferrante P., Moraleda J., Da Prada G., ...Daha Fazla
ANNALS OF ONCOLOGY, cilt.14, sa.4, ss.554-558, 2003 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
14
Sayı:
4
-
Basım Tarihi:
2003
-
Doi Numarası:
10.1093/annonc/mdg161
-
Dergi Adı:
ANNALS OF ONCOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.554-558
-
Anahtar Kelimeler:
acute myeloid leukemia, adjuvant therapy, breast cancer, high-dose chemotherapy, secondary myelodysplasia, ACUTE MYELOGENOUS LEUKEMIA, STEM-CELL TRANSPLANTATION, CYCLOPHOSPHAMIDE, RISK, MITOXANTRONE, MALIGNANCIES, EXPERIENCE, RADIATION, ABNORMALITIES, FLUOROURACIL
-
Ankara Üniversitesi Adresli:
Evet
Özet
Background: To determine the incidence of secondary myelodysplasia (sMDS) or acute myeloid leukemia (AML) in node-positive breast cancer patients who received high-dose chemotherapy (HDCT) followed by autologous stem-cell support as adjuvant therapy.